ISP V-B EF LP - 21 Oct 2021 Form 3 Insider Report for Enfusion, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
21 Oct 2021, 21:42:58 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
ISP V-B EF LP, By: ICONIQ Strategic Partners V-B, L.P., By: ICONIQ Strategic Partners V GP, L.P., By: ICONIQ Strategic Partners V TT GP, Ltd., By: Kevin Foster, Title: Authorized Signatory, /s/ Kevin Foster
Filing notes and source

Key filing fact

ISP V-B EF LP filed Form 3 for Enfusion, Inc. on 21 Oct 2021.

Key facts

  • This page summarizes ISP V-B EF LP's Form 3 filing for Enfusion, Inc..
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 21 Oct 2021, 21:42.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENFN holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,748,000
Date
21 Oct 2021
Ownership
Direct
Footnotes
F1, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENFN holding Derivative

Common Units of Enfusion Ltd. LLC

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
21 Oct 2021
Ownership
By ISP V Main Fund EF LLC
Underlying class
Class A Common Stock
Underlying amount
5,030,000
Exercise price
Footnotes
F2, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The shares are held by ISP V-B EF LP ("ISP V-B EF").

Footnote F2

The shares are held by ISP V Main Fund EF LLC ("ISP V EF").

Footnote F3

ICONIQ Strategic Partners V, L.P. ("ICONIQ V") is the sole managing member of ISP V EF. ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V and ISP V-B EF. ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP.

Footnote F4

Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Footnote F5

Common Units of Enfusion Ltd. LLC (the "Common Units") are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis (for which the Issuer may substitute cash) following the completion of the Issuer's initial public offering. The Common Units have no expiration date. At the time of any such exchange, an equal number of shares of the Class B common stock of the Issuer held by the Reporting Persons, which have no economic value and entitle holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally, are cancelled.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .